AMPH - Amphastar Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

AMPH is currently covered by 3 analysts with an average potential upside of $3.79 (23.73%) backed by displayed 50 price targets and 51 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 308.88 days.

Highest price target for AMPH is 43, Lowest price target is 23, average price target is 33.

Most recent stock forecast was given by JACOB HUGHES from WELLS FARGO on 17-May-2023. First documented stock forecast 25-Mar-2015.

Currently, out of the existing stock ratings of AMPH - 6 which are a Buy (66.67%), 3 which are a Hold (33.33%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

44

$-10.41 (-19.13%)

40

6 months 13 days ago

5/5 (100%)

$1.09 (4.36%)

86

Buy

41

$-13.41 (-24.65%)

40

8 months 29 days ago

10/10 (100%)

$4.72 (22.69%)

390

Buy

33

$-21.41 (-39.35%)

24

1 years 8 months 19 days ago

3/3 (100%)

$2.91 (17.37%)

375

Hold

18

3 years 4 months 21 days ago

1/1 (100%)

$5.8 (47.54%)

115

Hold

21

3 years 6 months 19 days ago

8/8 (100%)

$0.82 (5.67%)

191

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AMPH (Amphastar Pharmaceuticals) average time for price targets to be met?

On average it took 308.88 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on AMPH (Amphastar Pharmaceuticals) with a proven track record?

DAVID MARIS

Which analyst has the current lower performing score on AMPH (Amphastar Pharmaceuticals) with a proven track record?

ELLIOT WILBUR

Which analyst has the most public recommendations on AMPH (Amphastar Pharmaceuticals)?

David Maris works at WELLS FARGO and has 2 price targets and 4 ratings on AMPH

Which analyst is the currently most bullish on AMPH (Amphastar Pharmaceuticals)?

Elliot Wilbur with highest potential upside - $0

Which analyst is the currently most reserved on AMPH (Amphastar Pharmaceuticals)?

David Steinberg with lowest potential downside - -$31.41

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart